Patient satisfaction with methadone maintenance treatment: The relevance of participation in treatment and social functioning

Trujols, Joan; Garijo, Inmaculada; Siñol, Núria; Pozo, Juan del; Portella, Marı́a J.; Cobos, José Pérez de los

doi:10.1016/j.drugalcdep.2011.10.014

Cited by 45 publications

(55 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These findings are consistent with calls to increase patient participation in treatment decision making (Neale, 1998;Rance & Treloar, 2015;Trujols, 2012Trujols, , 2017 (Yarborough et al, 2016).…”

Section: Patient Views Of Opioid Pharmacotherapy Bio-delivery Systemssupporting

confidence: 79%

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Neale

Tompkins

Strang

2018

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

The technology for delivering opioid pharmacotherapy (OPT) is expanding. It is important to know what OPT patients think of these developments, and to find ways of enabling patients and clinicians to make informed decisions about which bio-delivery system to choose. We explored the views of current and former OPT patients with a history of heroin use to identify factors influencing their preferences regarding routes of OPT administration. Data were generated via seven focus groups conducted in London, United Kingdom. Participants (n=44) considered standard bio-delivery systems (liquid/linctus, tablet, injectables), emergent systems (implants, depot injections), and a hypothetical system (nasal sprays). Groups were audio-recorded, transcribed verbatim, coded using qualitative software, and analyzed inductively via Iterative Categorization. Participants were cautious of, but willing to consider, new ways of receiving OPT and they welcomed having more choice. Their preferences and decision-making processes were influenced by nine interconnected factors: 1. personal dislike of particular bio-delivery systems; 2. desired feelings following OPT administration; 3.perceived effectiveness of OPT bio-delivery systems; 4. concerns about side effects; 5. ability to control the OPT; 6. impact on daily lives; 7. concerns about OPT-related stigma; 8. need for psychosocial support; and 9. personal treatment goals. This complexity may make it difficult for patients and clinicians to evaluate the pros and cons of the expanding array of OPT bio-delivery systems and to arrive at clear conclusions. We therefore use the findings to Article accepted by Experimental and Clinical Psychopharmacology 3 construct a checklist that may facilitate discussions with patients when decisions about OPT need to be made. KEYWORDS

show abstract

Section: Patient Views Of Opioid Pharmacotherapy Bio-delivery Systemssupporting

confidence: 79%

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Neale

Tompkins

Strang

2018

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…It shows a strong positive relationship with treatment evaluation, emphasizing the significance of social reintegration in the evaluation of MAT. Social functioning has also been associated with patients' satisfaction with MAT (Trujols et al, 2012), and may therefore constitute an important common outcome parameter for patients as well as providers. Of course, as we collected no data on this, we cannot rule out that socially well-integrated patients are less likely to suffer from psychiatric comorbidities.…”

Section: Discussionmentioning

confidence: 99%

“…However, there is an increasing recognition that these constitute essential measures of MAT quality (Tiffany et al, 2012;Trujols et al, 2011;Uchtenhagen, 2015). Few studies have investigated subjective views of MAT episodes (Montagne, 2002;Stancliff, 2002), and, if so, mostly addressed patient satisfaction (Kelly et al, 2010;Marchand et al, 2011;Trujols et al, 2012). Fewer studies still have investigated the views of treatment providers (Becker and Fiellin, 2006).…”

Section: Introductionmentioning

confidence: 99%

Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective

Vogel

Nordt

Dürsteler

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

BACKGROUND: There is controversy about which outcome parameters should be employed to assess substance use treatment. Subjective measures of medication-assisted treatment (MAT) of opioid dependence are increasingly important. However, while patients' perspectives have been examined, the caregivers' views remain largely unknown. Here, we explore how physicians evaluate MAT, and which predictors are most relevant. METHODS: We conducted a retrospective cohort study of all MAT episodes with oral opioid agonists in the canton of Zurich between 1998 and 2013 using a case register. Termination forms of the register include a physician-completed assessment on the course of the treatment episode. Mixed model analysis was applied to determine relevant predictors. RESULTS: The analysis was based on 17,234 episodes from 7432 patients. Mean global assessment of the course of MAT was 'moderate'. The most important predictors for treatment evaluation by physicians were treatment break off as reason for termination (p<0.0001), psychological improvement throughout treatment (p<0.0001), wish for abstinence from the substitute (p<0.0001), social integration index at termination (p<0.0001), and social (p<0.0001) as well as medical (p<0.0001) improvement. The negative association of treatment break off with MAT assessment was more pronounced in semi-rural than urban areas (p<0.0001). CONCLUSION: Predictors relating to the well-being and functioning of the patient as well as the reasons underlying treatment termination appear to be more important for the treating physician's evaluation of medication-assisted treatment episodes than on-going substance use. Coming off the opioid medication plays a central role, independent of ongoing illicit substance use. Predictors relating to the well-being and functioning of the patient as well as the reasons underlying treatment termination appear to be more important for the treating physician's evaluation of medication-assisted treatment episodes than on-going substance use. Coming off the opioid medication plays a central role, independent of ongoing illicit substance use.

show abstract

“…In addition, an individual desire to be treated at these centers can contribute to his satisfaction and better social performance (16). The drug strongly affects the metabolism of the body due to the fact that it leads to malnutrition in people (17,18).…”

Section: Discussionmentioning

confidence: 99%

Comparing the Lifestyle and Sexual Satisfaction of Patients Received Methadone Maintenance Therapy with Those of Patients Received and Narcotics Anonymous

Emamgholi

Sharifi

Allameh

et al. 2018

Middle East J Rehabil Health Stud

View full text Add to dashboard Cite

Background: The objective of this study was to compare the lifestyles and sexual satisfaction of patients who received Narcotics Anonymous with patients who received methadone maintenance therapy. Methods: In this cross-sectional study, 50 patients who received Narcotics Anonymous were compared with 50 patients who underwent methadone maintenance treatment (MMT). The participants were chosen from the city of Ghazvin (Iran) in 2016 and they completed the lifestyle questionnaire and Larson sexual satisfaction questionnaire. Results:The results of multivariate analysis of variance showed significant differences between the 2 groups in the components of lifestyle so that the MMT group achieved higher scores in the subscale of weight control and nutrition, disease prevention, mental health, social health, drug prevention, accident prevention, and environmental health (P < 0.05), however, the difference between the 2 groups in components of health, exercise and fitness, and mental health was not significant (P = 0.000). Furthermore, independent t-test results showed that the 2 groups have no significant difference in sexual satisfaction (P = 0.000). Conclusions:The findings indicated the higher effectiveness of methadone maintenance therapy in MMT group compared to Narcotics Anonymous. It can be stated that the lifestyle was partly modified due to the avoidance of substance abuse in methadone maintenance treatment.

show abstract

Patient satisfaction with methadone maintenance treatment: The relevance of participation in treatment and social functioning

Cited by 45 publications

References 34 publications

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective

Comparing the Lifestyle and Sexual Satisfaction of Patients Received Methadone Maintenance Therapy with Those of Patients Received and Narcotics Anonymous

Contact Info

Product

Resources

About